Viewing Study NCT06454435


Ignite Creation Date: 2025-12-24 @ 10:40 PM
Ignite Modification Date: 2026-01-02 @ 1:04 AM
Study NCT ID: NCT06454435
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-12
First Post: 2024-06-06
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Conversion Therapy of Sintilimab in Combination With Fruquintinib and Chemotherapy Versus Sintilimab and Chemotherpay in Stage IV Gastric Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module